Evolv
San Francisco
About Evolv
Evolv provides an oral supplement, Evolv GLP-1®, engineered to support weight management and promote longevity. This supplement assists in managing food cravings and fosters metabolic well-being.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.8M
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2024)
- Website: biodrive.io
Industries & Categories
Dietary Supplements, Fitness, Wellness
Social Profiles
Canonical: https://fsome.com/organization/evolv-107444 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.